Skip to content

Sight Sciences, Inc. SGHT Preferred stock issuance

Preferred stock issuance at other companies

Solidion Technology, Inc. logo
Solidion Technology, Inc.STI
$241.55K
OS Therapies logo
OS TherapiesOSTX
$263.25K
Apollo Global Management logo
Apollo Global ManagementAPO
28.7M0.0%
Our Bond, Inc.
 logo
Our Bond, Inc. OBAI
$2K-33.3%
Kimberly-Clark logo
Kimberly-ClarkKMB
$0
Henry (Jack) & Associates logo
Henry (Jack) & AssociatesJKHY
$0

Other financials

Income statement

See full
Revenue$19.7M+12.5%
Gross profit$17.0M+12.5%
Operating income-$12.4M+10.4%
Net income-$13.0M+8.3%
EPS (diluted)-$0.24+14.3%

Balance sheet

See full
Cash & equivalents$85.0M-21.9%
Total debt$40.9M+1.1%
Total equity$53.9M-30.6%
Total assets$109.7M-15.4%

Cash flow

See full
Operating cash flow-$7.0M+39.4%
CapEx$60.0K
Free cash flow-$7.1M+38.9%

Valuation

See full
Market cap$294.9M+35.0%
Enterprise value$250.83M+59.0%
P/S3.7×+0.8×

Profitability

See full
Gross margin86.2%+0.5pp
Operating margin-44.8%-10.2pp
Net margin-46.8%-9.6pp
FCF margin-31.9%+0.2pp

Returns & leverage

See full
Return on equity-56.6%+4.3pp
Debt / equity0.8×+0.2×
Current ratio5.9×-4.6×

Where this comes from

Reported directly by Sight Sciences, Inc. in its filing.

Tagged under the XBRL concept us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants.

The official record: Sight Sciences, Inc.’s 10-K, filed March 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Sight Sciences, Inc.'s preferred stock issuance.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Sight Sciences, Inc.'s preferred stock issuance?
Sight Sciences, Inc. (SGHT) reported preferred stock issuance of $0 in Q4 2025.
How has Sight Sciences, Inc.'s preferred stock issuance changed year-over-year?
Sight Sciences, Inc.'s preferred stock issuance decreased by 100.0% year-over-year, from $78K to $0.
What does preferred stock issuance mean?
Represents the fair value of equity instruments, such as warrants, issued as part of debt financing agreements or capital raises. This metric highlights the dilutive impact and cost of capital associated with securing external funding.